. >>> aheld del haize is lower 3.7% from a year ago net profit missed forecasts coming in at 410 million euros they say they're confident of delivering synergy targets for this year and 2019 >>> novo nordisk is sharply lower. the world's top maker of diabetes drugs reported second quarter profit broadly in line with expectations. novo relies on the united states for half of its revenues that's a trend we're seeing with all the pharmaceutical companies, no doubt on the back of some tweets coming out from the u.s. president i'm happy to say patrick spencer from bairds is joining us on the show to discuss more let's talk about your take on the earnings season so far u.s. has been very strong, about 25% eps growth stronger than q1 even. q1 was a strong quarter. also seeing decent growth in europe as well >> yes, also the key is because everyone knows that this season was going to be strong it was really to look at guidance that's what we've been looking at closely positiveguidance has beat negative guidance for the third quarter running. that's the strongest it's been since '06. not only hav